Overview

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects

Status:
ENROLLING_BY_INVITATION

Trial end date:
2026-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.

Phase:

PHASE1

Details

Lead Sponsor:

Rhoshan Pharmaceuticals Inc

Treatments:

Aspirin
DNA modification methylase phi3TII, Bacteriophage phi-3T